Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This is a pilot, prospective, double-blinded, two-arm, randomized controlled trial of the efficacy of Frondanol in comparison to placebo in decreasing bowel inflammation in patients with a clinical diagnosis of inflammatory bowel disease who are in remission and on standard of care treatment.
Epistemonikos ID: 33f3f66536253fb271ef59b180767bfa328f12d8
First added on: Mar 23, 2022